MDR-TB to Pre-XDR-TB and XDR-TB Differences: Introduction, Differences, and Critical Clinical Differences

MDR-TB to Pre-XDR-TB and XDR-TB Differences- Introduction, Differences, and Critical Clinical Differences

Introduction The core difference between these forms of drug-resistant tuberculosis (DR-TB) lies in which specific medications the Mycobacterium tuberculosis bacteria can survive. As resistance progresses from MDR-TB to Pre-XDR-TB and finally XDR-TB, treatment becomes longer, more complex, and relies on scarcer second-line drugs. Differences Comparison …

Read more

Xpert MTB-XDR: Introduction, Principle, Procedure, Result-Interpretation, Uses, and Keynotes

The image shows a GeneXpert software interface displaying an Xpert MTB/XDR test result with M. tuberculosis (MTB) detected and a specific drug resistance profile.Key Findings:MTB DETECTED: Positive for Mycobacterium tuberculosis complex.Low FLQ Resistance DETECTED: Indicates low-level resistance to fluoroquinolones (e.g., levofloxacin or moxifloxacin).Resistance NOT DETECTED: No mutations were found for isoniazid (INH), amikacin (AMK), kanamycin (KAN), capreomycin (CAP), or ethionamide (ETH).This result is consistent with a pre-XDR-TB diagnosis, as there is resistance to fluoroquinolones but susceptibility to second-line injectables.

Introduction The Xpert MTB/XDR assay is an advanced molecular diagnostic tool designed by Cepheid to rapidly detect Mycobacterium tuberculosis complex (MTBC) and its resistance to multiple first- and second-line drugs. Launched in 2021, it is categorized as a “low complexity” automated nucleic acid amplification test …

Read more